Working both with Janssen Research and Development, a company that’s part of Johnson and Johnson and Moderna, a Cambridge, Massachusetts biotech firm, Health and Human Services (HHS) has taken a collaborative approach in order to speed-up the time it takes to develop and manufacture a vaccine for the COVID-19 virus.
Clinical research is usually done in a serial manner, but HHS’s approach could reduce vaccine development by months. According to an HHS press release, “Collaborating on clinical trial preparation now means the later clinical trial phases can begin immediately upon successful completion of the Phase 1 clinical trial currently underway. Working in parallel instead of taking the traditional sequential approach to vaccine development potentially shaves months off the timeline for vaccine development.”
This collaboration will hopefully result in a vaccine that is available in early 2021.
